MET and neoplasm: To identify tumor lines with aberrant c-Met signaling suitable for further examination of the effect of ABT-700, we evaluated a panel of 35 human cancer cell lines for MET amplification, c-Met protein expression and their dependence on c-Met activity for growth in vitro.